Your Heart May Be Influencing Your Financial Decisions: The Emerging Science of Neurofinance and Biometrics
When the Body Influences the Market Decision
For many years, financial decision-making was primarily studied through economic models, behavioral psychology, and statistical analysis. However, recent advances in neuroscience and biometric measurement are revealing another important dimension: the physiological condition of the human body can directly influence how financial risks and rewards are evaluated.
In other words, investment decisions may depend not only on available information, market expectations, and individual experience, but also on the biological state of the decision-maker at the precise moment a decision is made.
Two recent research developments offer particularly interesting evidence of this emerging relationship.
1. Breathing Patterns Can Change Risk-Taking Behavior
A study published in Neuron in 2026, titled "Slow Breathing Impacts Inter-Organ Dynamics Modulating Brain Function and Risk Behavior", investigated how controlled breathing influences the relationship between cardiac activity, brain function, and risky decision-making.
The research involved 41 healthy participants who performed financial risk-taking tasks while researchers monitored their brain activity using functional magnetic resonance imaging (fMRI), alongside cardiac activity, respiration, skin conductance, and pupil responses. The researchers compared participants' natural breathing patterns with a controlled breathing technique involving prolonged exhalation. The results revealed a significant finding: prolonged exhalation increased the frequency of risky choices. However, the underlying mechanism was particularly important.
The physiological changes increased cardiac parasympathetic activity and enhanced the brain's sensitivity to potential rewards, without producing a corresponding reduction in sensitivity to potential losses.
The findings suggest that the physiological state of the body can influence how the brain evaluates financial opportunities.
This creates an important implication for financial professionals: a decision-maker's momentary physiological condition may alter the relative importance assigned to potential gains and losses.
Importantly, the study does not demonstrate that controlled breathing improves investment performance. In fact, under the experimental conditions, it increased risk-taking.
2. Measuring the Brain During Real Financial Trading
Another important development comes from research published by the National Bureau of Economic Research (NBER) in 2026.
In the working paper "Measuring Neural Engagement in High-Stakes Trading", researchers examined the brain activity of professional day traders using wearable electroencephalography (EEG) devices during actual trading activities.
Unlike conventional laboratory experiments, this research investigated neural activity in real-world financial environments.
The researchers developed a psychophysiological Engagement Index to examine how neural engagement changed around trade execution.
Their findings revealed identifiable patterns of neural engagement, characterized by increases and subsequent decreases around trading decisions.
More importantly, trades associated with better outcomes were preceded by larger increases in neural engagement during the 30 seconds before execution.
Interestingly, baseline neural engagement did not demonstrate the same predictive value.
This suggests that the timing and dynamics of cognitive engagement may be more informative than an individual's general level of neural activity.
Although these findings do not establish a universal neural signature of profitable trading, they demonstrate the potential of wearable neurotechnology to investigate decision-making processes as they unfold in financial markets.
3. The Emergence of Real-Time Financial Biometrics
These developments point toward a new generation of financial assessment technologies
Traditional financial analysis evaluates market conditions, portfolio exposure, historical performance, and economic indicators.
Biometric and neurophysiological assessment introduces an additional analytical layer by examining the human processes behind financial decisions.
Several technologies are particularly relevant:
- Electroencephalography (EEG): Measures electrical activity in the brain and can help researchers investigate attention, cognitive engagement, and decision-related neural patterns.
- Heart Rate Variability (HRV): Measures variations in the intervals between consecutive heartbeats and provides information about aspects of autonomic nervous system regulation.
- Eye-Tracking and Pupillometry: Examine visual attention, information processing, and changes in pupil diameter associated with cognitive effort and physiological arousal.
- Galvanic Skin Response (GSR): Measures changes in skin conductance associated with sympathetic nervous system activity.
- Electrocardiography (ECG): Records the electrical activity of the heart and provides information about cardiac responses during decision-making.
- Functional Magnetic Resonance Imaging (fMRI): Allows researchers to investigate brain activity associated with reward evaluation, emotional processing, and risk assessment.
When these technologies are combined with behavioral and financial data, researchers can develop more comprehensive models of the mechanisms underlying investment and commercial decisions.
4. Implications for Financial Institutions and Professional Investors
The practical implications of neurofinance extend beyond individual traders.
Financial institutions, investment companies, trading organizations, and risk-management departments may eventually use validated biometric assessment systems to investigate several important questions:
- How does prolonged psychological or physiological stress influence investment decisions?
- Can changes in neural engagement help identify periods of impaired decision-making?
- How do physiological responses influence the evaluation of financial risk?
- Can biometric monitoring help identify behavioral patterns associated with impulsive trading?
- How does cognitive fatigue influence the interpretation of financial information?
These questions could contribute to the development of more sophisticated risk-management frameworks.
However, physiological signals should never be interpreted as direct indicators of investment competence, profitability, or psychological fitness without adequate validation.
A higher heart rate, increased neural engagement, or stronger physiological arousal does not automatically indicate a better or worse decision.
The objective is to understand the relationship between physiological signals, cognitive processes, and actual decision outcomes.
5. The Next Frontier: Integrating Neurofinance with Artificial Intelligence
The combination of wearable biometric technologies, artificial intelligence, and financial data analytics could eventually enable the development of real-time decision-support systems.
Such systems could integrate physiological indicators with trading histories, market conditions, and behavioral patterns to identify situations in which decision-making may be affected by fatigue, excessive arousal, or cognitive overload.
For example, an AI-supported financial assessment platform might identify recurring relationships between physiological stress indicators and impulsive trading behavior.
Rather than predicting market movements directly, such systems could focus on evaluating the human factors that influence financial decisions.
Nevertheless, significant research remains necessary. Data privacy, biometric consent, individual differences, measurement reliability, and the risk of misleading interpretations must be addressed before these technologies can be responsibly deployed in professional financial environments.
Conclusion: Financial Intelligence Must Understand the Human Body
The emerging field of neurofinance is challenging the traditional boundaries between economics, neuroscience, psychology, and biometric technology.
Recent research demonstrates that financial decision-making is not exclusively an intellectual process based on information and rational calculation. It is also influenced by the interaction between brain activity, cardiac regulation, physiological arousal, and cognitive evaluation.
This perspective creates opportunities for a more comprehensive understanding of financial behavior.
The next generation of financial intelligence may therefore require more than market data and predictive algorithms. It may also need scientifically validated methods for understanding the biological and neurological processes that shape human decisions.
The future of financial risk assessment may depend not only on understanding what investors decide, but also on understanding the physiological and neural conditions under which they make those decisions.
Neurofinance & Biometrics Lab Perspective: The human body is not separate from financial decision-making. It is part of the decision-making system itself.
